Fort Worth, TX, United States of America

Yuhong Zeng



 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuhong Zeng: Innovator in Pharmaceutical Formulations

Introduction

Yuhong Zeng is a notable inventor based in Fort Worth, TX (US), recognized for his contributions to the field of pharmaceutical formulations. He holds 2 patents that focus on innovative solutions for delivering therapeutic antibodies.

Latest Patents

Zeng's latest patents include a stable protein solution formulation containing a high concentration of an anti-VEGF antibody. This invention provides anti-VEGF antibodies formulated as high concentration, aqueous pharmaceutical compositions, suitable for injection, preferably an intravitreal injection. The aqueous pharmaceutical compositions are designed to deliver a high concentration of the antibody active ingredient to a patient while minimizing antibody aggregation and sub-visible particulate matter. The composition includes an antibody concentration of at least 50 mg/ml, along with a sugar, a buffering agent, and a surfactant.

Career Highlights

Yuhong Zeng is currently associated with Novartis AG, where he continues to advance his research and development efforts in the pharmaceutical industry. His work is pivotal in enhancing the efficacy and safety of therapeutic antibodies.

Collaborations

Zeng collaborates with esteemed colleagues, including Huixiang Zhang and Charles Boring, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yuhong Zeng's work in developing stable protein solutions for therapeutic applications exemplifies the critical role of inventors in advancing medical science. His contributions are significant in improving patient care through innovative pharmaceutical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…